Skip to main content
An official website of the United States government

Early Detection

Advances research to determine the effectiveness and clinical impact – harms and benefits – of cancer early detection technologies and practices, including imaging and molecular biomarker approaches. Fosters technological development, statistical modeling, and dissemination of scientific findings to promote early cancer detection practices.

On This Page

  • All Heading 2s will automatically be pulled in to this list.
  • Do not edit the content on this template.

Major Programs

Resources

Staff List

Photo Name, Email, Phone Room Group(s)/Office
LeeVan, Elyse, M.D., M.P.H.
elyse.leevan@nih.gov
240-276-7314
5E110 Program Officer | Early Detection
McCarty, Larae
larae.mccarty@nih.gov
240-276-5777
5E322 Program Specialist | Community Oncology and Prevention Trials
Early Detection
Miller, Eric, Ph.D.
eric.miller2@nih.gov
240-276-5336
5E212 Program Officer | Early Detection
Ong, Mary Jane
maryjane.ong@nih.gov
240-858-3296
5E120 Nurse Consultant | Early Detection
Pinsky, Paul, Ph.D.
paul.pinsky@nih.gov
240-276-7014
5E108 Chief | Early Detection
Saxena, Neeraj, Ph.D.
neeraj.saxena@nih.gov
240-276-6302
5E218 Program Officer | Early Detection
Zhu, Claire, Ph.D.
claire.zhu@nih.gov
240-276-7013
5E106 Program Officer | Early Detection

Grants

PI Name Sort descending PI Organization Title Grant Number Program Official
Boutros, Paul Christopher

University Of California Los Angeles
United States

Germline Determinants of Prostate Cancer Evolution 5R01CA270108-03 Guillermo Marquez, Ph.D.
Bower, Julienne E

University Of California Los Angeles
United States

Mindfulness Meditation for Younger Breast Cancer Survivors: Testing Digital Interventions in Clinical and Community Settings 5R01CA282416-02 Brennan Streck, Ph.D., RN, M.P.H.
Boyer, Thomas G

University Of Texas Hlth Science Center
United States

Pathological reprogramming of the m6A epitranscriptome in uterine fibroids 5R01HD106285-05 Goli Samimi, Ph.D., M.P.H.
Brand, Randall

University Of Pittsburgh At Pittsburgh
United States

Validation of biomarkers for risk prediction and early diagnosis of Pancreatic Adenocarcinoma 5U01CA200466-08 Matthew Young, Ph.D.
Brinkman, Tara M

St. Jude Children'S Research Hospital
United States

Culturally adapted mobile treatment of chronic pain in adolescent survivors of pediatric bone sarcoma 4R33CA280978-02 Rachel Altshuler, Ph.D.
Brown, Austin L

Baylor College Of Medicine
United States

A Systems Epidemiology Approach for Predicting Methotrexate Neurotoxicity in Pediatric Acute Leukemia 5R01CA272981-03 Rachel Altshuler, Ph.D.
Bruner, Deborah Watkins

Nrg Oncology Foundation, Inc.
United States

NRG Oncology NCORP Research Base-BIQSFP 3UG1CA189867-11S2 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Bryan, Angela

University Of Colorado
United States

Cannabis for Palliative Care in Cancer: A Placebo-controlled Randomized Trial of Full Spectrum Hemp-derived CBD/THC 5R01CA284860-03 Brennan Streck, Ph.D., RN, M.P.H.
Buczynski, Matthew Wallace

Virginia Polytechnic Inst And St Univ
United States

Anti-nociceptive actions of CART II in chemotherapy-induced peripheral neuropathy 5R01CA284075-03 Rachel Altshuler, Ph.D.
Buis, Lorraine R

University Of Michigan At Ann Arbor
United States

MyGI Diet for Colorectal Cancer Prevention 5R01CA255743-04 Nancy J. Emenaker, Ph.D., RDN, LD, FAND
Burgess, Mark Thomas

Sloan-Kettering Inst Can Research
United States

Clinical assessment of radiotherapy-induced vaginal toxicity with multiparametric ultrasound imaging 5R21CA290252-02 Goli Samimi, Ph.D., M.P.H.
Buszczak, Michael

Ut Southwestern Medical Center
United States

Developing ribosome biogenesis inhibitors for the prevention of cancer 5UG3CA290312-02 Kajal Biswas, Ph.D.
Butler, Kathleen Yost

Corewell Health
United States

Cancer Research Consortium of West Michigan (CRCWM) 3UG1CA189860-11S1 Vanessa A. White, M.P.H.
Butryn, Meghan

Drexel University
United States

Efficacy of a multi-level intervention designed to promote adherence to WCRF/AICR dietary guidelines for cancer prevention 1R01CA288323-01A1 Nancy J. Emenaker, Ph.D., RDN, LD, FAND
Cai, Long

California Institute Of Technology
United States

Understanding the role of tumor microenvironment in low grade glioma progression to malignancy 4U01CA294551-02 Sidney Fu, M.D.